News

Learn how and why East Indian Sandalwood Oil (EISO) is making international headlines as a unique, non-substitutable botanical drug candidate.

Viroxis Secures Sandalwood Supply Agreement with TFS Corporation

Posted on

SAN ANTONIO, Texas and Perth, Western Australia, 28th October 2009: ViroXis Corporation today announced a multi-million dollar agreement with TFS Corporation (ASX: TFC) to supply up to three tonnes of East India Sandalwood Oil per annum for the development of its botanical drug, albuterpenoids. The long-term supply agreement is conditional upon ViroXis gaining regulatory approval for commercialisation of albuterpenoids. The […]Read More Viroxis Secures Sandalwood Supply Agreement with TFS Corporation